|Articles|September 30, 2022
Bristol Myers Squibb and ConcertAI Announce Launch of Digital Clinical Trial Solution
Offering seeks to reduce or eliminate duplicative data entry and constant data monitoring.
Advertisement
ConcertAI announced the launch of its new Digital Trial Software-as-a-Service solution. Developed in partnership with Bristol Myers Squibb and powered by ConcertAI's real-world data, Digital Trial Solution integrates clinical research and clinical practice to simplify patient identification, consent, IRB approval, and contract negotiations.
Read more about the solution
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Clinical Trials in 2026: Platformization, AI Fluency, and the Redrawing of the Value Chain
2
Breaking Out of AI Pilot Mode in Clinical Development
3
ACT Brief: Community Sites Compete on Readiness, COA Licensing Bottlenecks Slow Start-Up, and AI’s Foundations in Pharmacovigilance
4
The Challenges of Buying Blind: Why Providing the Clinical Outcome Assessment Measure Prior to License Execution Would Significantly Benefit Clinical Trial Set-Up
5